PALI · Palisade Bio, Inc.
$2.07
+0.06 (+2.99%)
At close · Aug 25
Market Cap
$350.28M
Shares
174.27M
Private capital raises reported to the SEC on Form D under Regulation D, showing the offering size, amount sold, minimum investment and number of investors. Public operating companies rarely raise capital this way, so this page is often empty.
| Filed | Type | Industry | Offering | Sold | Exemptions |
|---|---|---|---|---|---|
| 2024-05-10 | New | Biotechnology | $3,999,942 | $3,999,942 | 06b |
| 2024-02-13 | New | Biotechnology | $2,502,717 | $2,502,717 | 06b |
| 2023-04-10 | New | Biotechnology | $4,003,205 | $4,003,205 | 06b |
| 2023-01-19 | New | Biotechnology | $2,500,000 | $2,500,000 | 06b |
| 2022-05-20 | New | Biotechnology | $2,356,127 | $2,356,127 | 06b |
| 2020-01-28 | New | Biotechnology | $7,555,553 | $7,555,553 | 06b |
Showing 1–6 of 6 filings
Key facts
CIK
1357459
CUSIP
696389402
13F (30d)
119 filings
118 filers
Visit website
Investor relations